Summary
The effect in mice of chronic administration of the beta-adrenergic agonist clenbuterol was studied using four pharmacological tests, two of which are predictive of antidepressant activity in man. The suppressive effect of acute administration of the beta-adrenergic agonist in two tests unrelated to antidepressant activity, locomotor activity and investigation of food, was attenuated after chronic treatment. However, in the two tests which are predictive of antidepressant activity, antagonism of reserpine induced hypothermia and potentiation of yohimbine toxicity, the effect of clenbuterol was greater following chronic treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbrachio, M. P., Cattabeni, F., Coen, E., Torres-Hernandez, Y., Omini, C.: Beta-adrenoceptor desensitization in rat lung; functional and biochemical aspects. Eur. J. Pharmacol.89, 35–42 (1983).
Banerjee, S. P., Rung, L. S., Riggi, S. J., Chanda, S. K.: Development of beta-adrenergic receptor subsensitivity by antidepressants. Nature268, 455–456 (1977).
Bergstrom, D. A., Kellar, K. J.: Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. J. Pharmacol. Exp. Ther.209, 256–261 (1979).
Boissier, J. R., Simon, P., Lwoff. J. M.: L'utilisation d'une réaction particulière d'exploration de la Souris pour l'étude des médicaments psychotropes. Thérapie19, 571–583 (1964).
Borsini, F., Bendotti, C., Thurlby, P., Samanin, R.: Evidence that systemically administered salbutamol reduces food-intake in rats by acting on central beta-adrenergic sites. Life Sci.30, 905–911 (1982).
Bourin, M., Poncelet, M., Chermat, R., Simon, P.: The value of the reserpine test in psychopharmacology. Arzneim.-Forsch./Drug Res.33, 1175–1176 (1983).
Bretz, U., Martin, U., Mazzoni, L., Ney, U. M.: Beta-adrenergic tachyphylaxis in the rat and its reversal and prevention by ketotifen. Eur. J. Pharmacol.86, 321–328 (1983).
Conolly, M. F., Davies, D. S., Dollery, C. T., George, C. F.: Resistance to beta-adrenoceptor stimulants (a possible explanation for the rise in asthma deaths). Br. J. Pharmacol.43, 389–402 (1971).
Dibner, M. D., Molinoff, P. B.: Agonist induced changes in beta-adrenergic receptor density and receptor-mediated responsiveness in slices of rat cerebral cortex. J. Pharmacol. Exp. Ther.210, 433–439 (1979).
Diquet, B., Doare, L., Simon, P.: Determination of clenbuterol in the high nanogram range in plasma of mice by H.P.L.C. with amperometric detection. J. Chromato. Biomed. Appl.336, 415–421 (1984).
Dooley, D. H., Delini-Stula, A., Mogilnicka, F., Hauser, K., Billiger, H.: Some neurochemical and behavioral effects of clenbuterol a centrally acting beta-adrenergic agonist. 5th CA Symposium, Goteborg 1983, Abstract no. 114, p. 117 (1983).
Dooley, D. H., Hauser, L.: Subchronic infusion of clenbuterol: a beta-adrenergic agonist, decreases the cerebellar beta-receptors. Neurosci. Lett.36, 93–97 (1983).
Douglas, J. S., Lewis, A. J., Ridgway, P., Brink, C., Bouhuys, A.: Tachyphylaxis to beta-adrenoceptor agonists in guinea-pig airway smooth musclein vivo andin vitro. Eur. J. Pharmacol.42, 195–205 (1977).
Dumeur, G., Hue, B., Mouries, M. A., Lwoff, J. M.: “Tantale” test: simultaneous study of two behaviour patterns in mice. 11th CINP Congress, Vienna, July 9–14, Abstract, p. 235 (1978 a).
Dumeur, G., Hue, B., Mouries, M. A., Lwoff, J. M.: Action des médicaments psychotropes sur un test de comportement chez la Souris (test de Tantale). 7th Int. Cong. Pharmacol. IUPHAR, July 16–21, Abstract (1978 b).
Francès, H., Puech, A. J., Simon, P.: Profil psychopharmacologique de l'isoprénaline et du salbutamol. J. Pharmacol. (Paris)9, 25–34 (1982).
Francès, H., Danti, S., Simon, P.: Test de Tantale, activité motrice et stimulants beta-adrénergiques. J. Pharmacol. (Paris)13, 135 (1982).
Francès, H., Danti, S., Puech, A. J., Simon, P.: Disappearance of the decreasing in biting behavior induced by clenbuterol, a beta-adrenergic agonist, after chronic administration. Pharmacol. Biochem. and Behav.21, 313–316 (1984).
Goldschmidt, P. L., Francès, H., Simon, P.: Stimulation of beta-adrenergic receptors and spontaneous motor activity in mice. Pharmacol. Biochem. and Behav.21, 177–180 (1984).
Hall, H., Sallemark, M., Ross, S. B.: Clenbuterol, a central beta-adrenoceptor agonist. Acta Pharmacol. Toxicol.47, 159–160 (1980).
Johansson, S. R. M., Andersson, R. G. G.: Mechanisms of beta-adrenergic desensitization in rat myometrium. Acta Pharmacol. Toxicol.49, 241–247 (1981).
Jouvent, R., Ghozlan, A., Puech, A. J., Lecrubier, Y., Simon, P., Widlocher, D.: Étude contrôlée clomipramine/clenbuterol chez les déprimés hospitalisés. Ass. Française de Psychiatrie Biologique, 25 October 1983.
Lam, V., Bar, H. P.: Adrenaline-induced desensitization of liver adenylate cyclase. Biochem. Pharmacol.25, 2103–2104 (1976).
Lecrubier, Y., Puech, A. J., Jouvent, R., Simon, P., Widlocher, D.: A beta-adrenergic stimulant, salbutamol vs clomipramine in depression: a controlled study. Br. J. Psychiat.136, 354–358 (1980).
Leibowitz, S. F.: Ingestion in the satiated rat: role of alpha and beta receptors in mediating effects of hypothalamic adrenergic stimulation. Physiol. Behav.14, 743–754 (1975).
Lerer, B., Ebstein, R. P., Belmaker, R. M.: Subsensitivity of human beta-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology75, 169–172 (1981).
Lin, C. S., Hurwitz, L., Jenne, J., Avner, B. P.: Mechanism of isoproterenol induced desensitization of tracheal smooth muscle. J. Pharmacol. Exp. Ther.203, 12–22 (1977).
Malik, J. B.: Potentiation of yohimbine-induced lethality in mice: predictor of antidepressant potential. Drug Development Res.3, 357–363 (1983).
Mickey, J., Tate, R., Lefkowitz, R. J.: Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (−)isoproterenolin vitro. J. Biol. Chem.250, 5727–5729 (1975).
Moberg, G. P., Clark, C. R., Robinson, D. W.: Observation on the ontogeny of the feeding response to beta-adrenergic agonists and antagonists. Br. Vet. J.129, 27 (1973).
Przegalinski, E., Baran, L., Kedrek, G.: The central action of salbutamol, a beta-agonist with a potential antidepressant activity. Pol. J. Pharm. Pharmacol.32, 485–493 (1980).
Przegalinski, E., Siwanowicz, J., Bigajska, K., Baran, L.: Chronic treatment with electroconvulsive shock prevents the salbutamol-induced hypoactivity in rats. J. Pharm. Pharmacol.36, 626–628 (1984).
Przegalinski, E., Baran, L., Siwanowicz, J.: The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats. Psychopharmacol.80, 355–359 (1983).
Ross, S. B.: Antagonism of reserpine-induced hypothermia in mice by some beta-adrenoceptor agonist. Acta Pharmacol. Toxicol.47, 347–350 (1980).
Shear, M., Insel, P., Melmon, K. L., Coffino, P.: Agonist-specific refractoriness induced by isoproterenol. Studies with mutant cells. J. Biol. Chem.251, 7572–7576 (1976).
Simon, P., Lecrubier, Y., Jouvent, R., Puech, A. J., Allilaire, J. F., Widlocher, D.: Experimental and clinical evidence of the antidepressant effect of a beta-adrenergic stimulant. Psychol. Med.8, 335–338 (1978).
Simon, P., Lecrubier, Y., Jouvent, R., Puech, A. J., Widlocher, D.: Beta-receptor stimulation in the treatment of depression. In: Frontiers in Biochemical and Pharmacological Research in Depression (Usdin, E., et al., eds.), pp. 293–299. New York: Raven Press. 1984.
Souto, M., Francès, H., Lecrubier, Y., Puech, A. J., Simon, P.: Antagonism by d,l-propranolol of imipramine effects in mice. Eur. J. Pharmacol.60, 105–108 (1979).
Svedmyr, N., Larsson, S., Thiringer, G.: Studies of resistance to long-acting adrenergic beta-stimulators in asthmatic patients. Br. Med. J.2, 668 (1974).
U'Prichard, D. C., Enna, S. J.: In vitro modulation of CNS beta-receptor number by antidepressants and beta-agonists. Eur. J. Pharmacol.59, 297–301 (1979).
Widlocher, D., Simon, P., Allilaire, J. F., Jouvent, R., Lecurbier, Y., Puech, A. J.: Une nouvelle approche dans le traitement des états dépressifs: le salbutamol. Ann. Med. Interne129, 419–422 (1978).
Willner, P.: The validity of animal models of depression. Psychopharmacol.83, 1–16 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Francès, H., Diquet, B., Goldschmidt, P. et al. Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol. J. Neural Transmission 62, 65–76 (1985). https://doi.org/10.1007/BF01260416
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01260416